nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—epilepsy syndrome	0.235	1	CbGaD
Nadolol—ABCB1—Levetiracetam—epilepsy syndrome	0.0719	0.208	CbGbCtD
Nadolol—ABCB1—Clobazam—epilepsy syndrome	0.0498	0.144	CbGbCtD
Nadolol—ABCB1—Lamotrigine—epilepsy syndrome	0.048	0.139	CbGbCtD
Nadolol—ABCB1—Carbamazepine—epilepsy syndrome	0.0413	0.12	CbGbCtD
Nadolol—ABCB1—Phenytoin—epilepsy syndrome	0.037	0.107	CbGbCtD
Nadolol—ABCB1—Phenobarbital—epilepsy syndrome	0.033	0.0957	CbGbCtD
Nadolol—ABCB1—Midazolam—epilepsy syndrome	0.0325	0.0944	CbGbCtD
Nadolol—ABCB1—Diazepam—epilepsy syndrome	0.0313	0.0907	CbGbCtD
Nadolol—Constipation—Oxcarbazepine—epilepsy syndrome	0.000156	0.000523	CcSEcCtD
Nadolol—Vision blurred—Valproic Acid—epilepsy syndrome	0.000155	0.00052	CcSEcCtD
Nadolol—Body temperature increased—Felbamate—epilepsy syndrome	0.000155	0.000518	CcSEcCtD
Nadolol—Vomiting—Acetazolamide—epilepsy syndrome	0.000155	0.000518	CcSEcCtD
Nadolol—Diarrhoea—Propofol—epilepsy syndrome	0.000155	0.000518	CcSEcCtD
Nadolol—Pruritus—Levetiracetam—epilepsy syndrome	0.000155	0.000518	CcSEcCtD
Nadolol—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000154	0.000516	CcSEcCtD
Nadolol—Insomnia—Lamotrigine—epilepsy syndrome	0.000153	0.000513	CcSEcCtD
Nadolol—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000152	0.00051	CcSEcCtD
Nadolol—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000152	0.000509	CcSEcCtD
Nadolol—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000152	0.000509	CcSEcCtD
Nadolol—Body temperature increased—Zonisamide—epilepsy syndrome	0.000152	0.000507	CcSEcCtD
Nadolol—Asthenia—Fosphenytoin—epilepsy syndrome	0.000151	0.000507	CcSEcCtD
Nadolol—Visual impairment—Gabapentin—epilepsy syndrome	0.000151	0.000507	CcSEcCtD
Nadolol—Alopecia—Pregabalin—epilepsy syndrome	0.000151	0.000507	CcSEcCtD
Nadolol—Fatigue—Carbamazepine—epilepsy syndrome	0.000151	0.000506	CcSEcCtD
Nadolol—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000151	0.000505	CcSEcCtD
Nadolol—Weight increased—Topiramate—epilepsy syndrome	0.00015	0.000503	CcSEcCtD
Nadolol—Constipation—Carbamazepine—epilepsy syndrome	0.00015	0.000502	CcSEcCtD
Nadolol—Pain—Carbamazepine—epilepsy syndrome	0.00015	0.000502	CcSEcCtD
Nadolol—Dizziness—Propofol—epilepsy syndrome	0.00015	0.000501	CcSEcCtD
Nadolol—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000149	0.000501	CcSEcCtD
Nadolol—Pruritus—Fosphenytoin—epilepsy syndrome	0.000149	0.0005	CcSEcCtD
Nadolol—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000149	0.000499	CcSEcCtD
Nadolol—Asthenia—Vigabatrin—epilepsy syndrome	0.000147	0.000494	CcSEcCtD
Nadolol—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000147	0.000493	CcSEcCtD
Nadolol—Flatulence—Pregabalin—epilepsy syndrome	0.000147	0.000492	CcSEcCtD
Nadolol—Depression—Topiramate—epilepsy syndrome	0.000147	0.000491	CcSEcCtD
Nadolol—Tinnitus—Gabapentin—epilepsy syndrome	0.000146	0.00049	CcSEcCtD
Nadolol—Dizziness—Midazolam—epilepsy syndrome	0.000146	0.00049	CcSEcCtD
Nadolol—Body temperature increased—Clonazepam—epilepsy syndrome	0.000146	0.000489	CcSEcCtD
Nadolol—Fatigue—Lamotrigine—epilepsy syndrome	0.000146	0.000489	CcSEcCtD
Nadolol—Pruritus—Vigabatrin—epilepsy syndrome	0.000145	0.000487	CcSEcCtD
Nadolol—Asthenia—Diazepam—epilepsy syndrome	0.000145	0.000486	CcSEcCtD
Nadolol—Body temperature increased—Phenytoin—epilepsy syndrome	0.000145	0.000486	CcSEcCtD
Nadolol—Constipation—Lamotrigine—epilepsy syndrome	0.000145	0.000485	CcSEcCtD
Nadolol—Pain—Lamotrigine—epilepsy syndrome	0.000145	0.000485	CcSEcCtD
Nadolol—Nausea—Acetazolamide—epilepsy syndrome	0.000145	0.000484	CcSEcCtD
Nadolol—Dizziness—Levetiracetam—epilepsy syndrome	0.000144	0.000484	CcSEcCtD
Nadolol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000144	0.000483	CcSEcCtD
Nadolol—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000144	0.000483	CcSEcCtD
Nadolol—Cough—Valproic Acid—epilepsy syndrome	0.000144	0.000482	CcSEcCtD
Nadolol—Vomiting—Propofol—epilepsy syndrome	0.000144	0.000481	CcSEcCtD
Nadolol—Pruritus—Diazepam—epilepsy syndrome	0.000143	0.000479	CcSEcCtD
Nadolol—Conjunctivitis—Topiramate—epilepsy syndrome	0.000143	0.000479	CcSEcCtD
Nadolol—Rash—Propofol—epilepsy syndrome	0.000143	0.000477	CcSEcCtD
Nadolol—Dermatitis—Propofol—epilepsy syndrome	0.000142	0.000477	CcSEcCtD
Nadolol—Hypertension—Valproic Acid—epilepsy syndrome	0.000142	0.000477	CcSEcCtD
Nadolol—Vomiting—Midazolam—epilepsy syndrome	0.000141	0.000471	CcSEcCtD
Nadolol—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000141	0.000471	CcSEcCtD
Nadolol—Asthenia—Felbamate—epilepsy syndrome	0.00014	0.000471	CcSEcCtD
Nadolol—Vision blurred—Pregabalin—epilepsy syndrome	0.00014	0.00047	CcSEcCtD
Nadolol—Chest pain—Valproic Acid—epilepsy syndrome	0.00014	0.00047	CcSEcCtD
Nadolol—Rash—Midazolam—epilepsy syndrome	0.000139	0.000467	CcSEcCtD
Nadolol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000139	0.000467	CcSEcCtD
Nadolol—Dermatitis—Midazolam—epilepsy syndrome	0.000139	0.000467	CcSEcCtD
Nadolol—Vomiting—Levetiracetam—epilepsy syndrome	0.000139	0.000465	CcSEcCtD
Nadolol—Alopecia—Gabapentin—epilepsy syndrome	0.000139	0.000465	CcSEcCtD
Nadolol—Pruritus—Felbamate—epilepsy syndrome	0.000139	0.000464	CcSEcCtD
Nadolol—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000138	0.000464	CcSEcCtD
Nadolol—Diarrhoea—Diazepam—epilepsy syndrome	0.000138	0.000464	CcSEcCtD
Nadolol—Rash—Levetiracetam—epilepsy syndrome	0.000138	0.000461	CcSEcCtD
Nadolol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000138	0.000461	CcSEcCtD
Nadolol—Asthenia—Zonisamide—epilepsy syndrome	0.000138	0.000461	CcSEcCtD
Nadolol—Agranulocytosis—Topiramate—epilepsy syndrome	0.000137	0.00046	CcSEcCtD
Nadolol—Dry mouth—Valproic Acid—epilepsy syndrome	0.000137	0.00046	CcSEcCtD
Nadolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000136	0.000455	CcSEcCtD
Nadolol—Pruritus—Zonisamide—epilepsy syndrome	0.000136	0.000454	CcSEcCtD
Nadolol—Flatulence—Gabapentin—epilepsy syndrome	0.000135	0.000451	CcSEcCtD
Nadolol—Oedema—Valproic Acid—epilepsy syndrome	0.000135	0.000451	CcSEcCtD
Nadolol—Bradycardia—Topiramate—epilepsy syndrome	0.000134	0.00045	CcSEcCtD
Nadolol—Nausea—Propofol—epilepsy syndrome	0.000134	0.00045	CcSEcCtD
Nadolol—Vomiting—Fosphenytoin—epilepsy syndrome	0.000134	0.000449	CcSEcCtD
Nadolol—Diarrhoea—Felbamate—epilepsy syndrome	0.000134	0.000449	CcSEcCtD
Nadolol—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000134	0.000448	CcSEcCtD
Nadolol—Dizziness—Diazepam—epilepsy syndrome	0.000134	0.000448	CcSEcCtD
Nadolol—Syncope—Pregabalin—epilepsy syndrome	0.000134	0.000448	CcSEcCtD
Nadolol—Rash—Fosphenytoin—epilepsy syndrome	0.000133	0.000445	CcSEcCtD
Nadolol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000133	0.000445	CcSEcCtD
Nadolol—Asthenia—Clonazepam—epilepsy syndrome	0.000133	0.000444	CcSEcCtD
Nadolol—Asthenia—Phenytoin—epilepsy syndrome	0.000132	0.000441	CcSEcCtD
Nadolol—Nausea—Midazolam—epilepsy syndrome	0.000131	0.00044	CcSEcCtD
Nadolol—Hallucination—Topiramate—epilepsy syndrome	0.000131	0.00044	CcSEcCtD
Nadolol—Diarrhoea—Zonisamide—epilepsy syndrome	0.000131	0.000439	CcSEcCtD
Nadolol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000131	0.000439	CcSEcCtD
Nadolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000131	0.000439	CcSEcCtD
Nadolol—Pruritus—Clonazepam—epilepsy syndrome	0.000131	0.000438	CcSEcCtD
Nadolol—Vomiting—Vigabatrin—epilepsy syndrome	0.000131	0.000438	CcSEcCtD
Nadolol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.00013	0.000436	CcSEcCtD
Nadolol—Cough—Pregabalin—epilepsy syndrome	0.00013	0.000435	CcSEcCtD
Nadolol—Pruritus—Phenytoin—epilepsy syndrome	0.00013	0.000435	CcSEcCtD
Nadolol—Nausea—Levetiracetam—epilepsy syndrome	0.00013	0.000435	CcSEcCtD
Nadolol—Rash—Vigabatrin—epilepsy syndrome	0.00013	0.000434	CcSEcCtD
Nadolol—Dizziness—Felbamate—epilepsy syndrome	0.000129	0.000434	CcSEcCtD
Nadolol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000129	0.000434	CcSEcCtD
Nadolol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000129	0.000432	CcSEcCtD
Nadolol—Vision blurred—Gabapentin—epilepsy syndrome	0.000129	0.000431	CcSEcCtD
Nadolol—Hypertension—Pregabalin—epilepsy syndrome	0.000129	0.000431	CcSEcCtD
Nadolol—Vomiting—Diazepam—epilepsy syndrome	0.000129	0.000431	CcSEcCtD
Nadolol—Anorexia—Valproic Acid—epilepsy syndrome	0.000128	0.000429	CcSEcCtD
Nadolol—Rash—Diazepam—epilepsy syndrome	0.000128	0.000427	CcSEcCtD
Nadolol—Dermatitis—Diazepam—epilepsy syndrome	0.000127	0.000427	CcSEcCtD
Nadolol—Visual impairment—Topiramate—epilepsy syndrome	0.000127	0.000426	CcSEcCtD
Nadolol—Chest pain—Pregabalin—epilepsy syndrome	0.000127	0.000425	CcSEcCtD
Nadolol—Dizziness—Zonisamide—epilepsy syndrome	0.000127	0.000425	CcSEcCtD
Nadolol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000126	0.000423	CcSEcCtD
Nadolol—Hypotension—Valproic Acid—epilepsy syndrome	0.000126	0.000421	CcSEcCtD
Nadolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000126	0.000421	CcSEcCtD
Nadolol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000126	0.00042	CcSEcCtD
Nadolol—Nausea—Fosphenytoin—epilepsy syndrome	0.000125	0.000419	CcSEcCtD
Nadolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000125	0.000418	CcSEcCtD
Nadolol—Vomiting—Felbamate—epilepsy syndrome	0.000124	0.000417	CcSEcCtD
Nadolol—Dry mouth—Pregabalin—epilepsy syndrome	0.000124	0.000416	CcSEcCtD
Nadolol—Pruritus—Carbamazepine—epilepsy syndrome	0.000124	0.000415	CcSEcCtD
Nadolol—Rash—Felbamate—epilepsy syndrome	0.000123	0.000414	CcSEcCtD
Nadolol—Dermatitis—Felbamate—epilepsy syndrome	0.000123	0.000413	CcSEcCtD
Nadolol—Tinnitus—Topiramate—epilepsy syndrome	0.000123	0.000412	CcSEcCtD
Nadolol—Syncope—Gabapentin—epilepsy syndrome	0.000123	0.00041	CcSEcCtD
Nadolol—Dizziness—Clonazepam—epilepsy syndrome	0.000122	0.000409	CcSEcCtD
Nadolol—Nausea—Vigabatrin—epilepsy syndrome	0.000122	0.000409	CcSEcCtD
Nadolol—Vomiting—Zonisamide—epilepsy syndrome	0.000122	0.000408	CcSEcCtD
Nadolol—Insomnia—Valproic Acid—epilepsy syndrome	0.000122	0.000407	CcSEcCtD
Nadolol—Oedema—Pregabalin—epilepsy syndrome	0.000122	0.000407	CcSEcCtD
Nadolol—Asthenia—Lamotrigine—epilepsy syndrome	0.000121	0.000407	CcSEcCtD
Nadolol—Dizziness—Phenytoin—epilepsy syndrome	0.000121	0.000406	CcSEcCtD
Nadolol—Rash—Zonisamide—epilepsy syndrome	0.000121	0.000405	CcSEcCtD
Nadolol—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000121	0.000405	CcSEcCtD
Nadolol—Dermatitis—Zonisamide—epilepsy syndrome	0.000121	0.000404	CcSEcCtD
Nadolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000121	0.000404	CcSEcCtD
Nadolol—Nausea—Diazepam—epilepsy syndrome	0.00012	0.000402	CcSEcCtD
Nadolol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.00012	0.000402	CcSEcCtD
Nadolol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00012	0.000402	CcSEcCtD
Nadolol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00012	0.000401	CcSEcCtD
Nadolol—Pruritus—Lamotrigine—epilepsy syndrome	0.00012	0.000401	CcSEcCtD
Nadolol—Shock—Pregabalin—epilepsy syndrome	0.00012	0.000401	CcSEcCtD
Nadolol—Cough—Gabapentin—epilepsy syndrome	0.000119	0.000399	CcSEcCtD
Nadolol—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000118	0.000397	CcSEcCtD
Nadolol—Hypertension—Gabapentin—epilepsy syndrome	0.000118	0.000395	CcSEcCtD
Nadolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000118	0.000394	CcSEcCtD
Nadolol—Vomiting—Clonazepam—epilepsy syndrome	0.000117	0.000393	CcSEcCtD
Nadolol—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000117	0.000392	CcSEcCtD
Nadolol—Alopecia—Topiramate—epilepsy syndrome	0.000117	0.000391	CcSEcCtD
Nadolol—Vomiting—Phenytoin—epilepsy syndrome	0.000117	0.000391	CcSEcCtD
Nadolol—Rash—Clonazepam—epilepsy syndrome	0.000116	0.00039	CcSEcCtD
Nadolol—Dermatitis—Clonazepam—epilepsy syndrome	0.000116	0.00039	CcSEcCtD
Nadolol—Chest pain—Gabapentin—epilepsy syndrome	0.000116	0.00039	CcSEcCtD
Nadolol—Nausea—Felbamate—epilepsy syndrome	0.000116	0.00039	CcSEcCtD
Nadolol—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000116	0.000389	CcSEcCtD
Nadolol—Fatigue—Valproic Acid—epilepsy syndrome	0.000116	0.000388	CcSEcCtD
Nadolol—Anorexia—Pregabalin—epilepsy syndrome	0.000116	0.000388	CcSEcCtD
Nadolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000116	0.000388	CcSEcCtD
Nadolol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000116	0.000388	CcSEcCtD
Nadolol—Rash—Phenytoin—epilepsy syndrome	0.000116	0.000387	CcSEcCtD
Nadolol—Dermatitis—Phenytoin—epilepsy syndrome	0.000116	0.000387	CcSEcCtD
Nadolol—Rash—Oxcarbazepine—epilepsy syndrome	0.000115	0.000385	CcSEcCtD
Nadolol—Constipation—Valproic Acid—epilepsy syndrome	0.000115	0.000385	CcSEcCtD
Nadolol—Pain—Valproic Acid—epilepsy syndrome	0.000115	0.000385	CcSEcCtD
Nadolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000115	0.000385	CcSEcCtD
Nadolol—Nausea—Zonisamide—epilepsy syndrome	0.000114	0.000381	CcSEcCtD
Nadolol—Dry mouth—Gabapentin—epilepsy syndrome	0.000114	0.000381	CcSEcCtD
Nadolol—Hypotension—Pregabalin—epilepsy syndrome	0.000114	0.000381	CcSEcCtD
Nadolol—Flatulence—Topiramate—epilepsy syndrome	0.000113	0.000379	CcSEcCtD
Nadolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000112	0.000375	CcSEcCtD
Nadolol—Oedema—Gabapentin—epilepsy syndrome	0.000112	0.000373	CcSEcCtD
Nadolol—Vomiting—Carbamazepine—epilepsy syndrome	0.000111	0.000373	CcSEcCtD
Nadolol—Rash—Carbamazepine—epilepsy syndrome	0.00011	0.00037	CcSEcCtD
Nadolol—Dermatitis—Carbamazepine—epilepsy syndrome	0.00011	0.00037	CcSEcCtD
Nadolol—Insomnia—Pregabalin—epilepsy syndrome	0.00011	0.000368	CcSEcCtD
Nadolol—Nausea—Clonazepam—epilepsy syndrome	0.00011	0.000367	CcSEcCtD
Nadolol—Shock—Gabapentin—epilepsy syndrome	0.00011	0.000367	CcSEcCtD
Nadolol—Paraesthesia—Pregabalin—epilepsy syndrome	0.000109	0.000366	CcSEcCtD
Nadolol—Nausea—Phenytoin—epilepsy syndrome	0.000109	0.000365	CcSEcCtD
Nadolol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000108	0.000363	CcSEcCtD
Nadolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000108	0.000363	CcSEcCtD
Nadolol—Vision blurred—Topiramate—epilepsy syndrome	0.000108	0.000363	CcSEcCtD
Nadolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000108	0.000361	CcSEcCtD
Nadolol—Vomiting—Lamotrigine—epilepsy syndrome	0.000108	0.00036	CcSEcCtD
Nadolol—Rash—Lamotrigine—epilepsy syndrome	0.000107	0.000357	CcSEcCtD
Nadolol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000107	0.000357	CcSEcCtD
Nadolol—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000106	0.000356	CcSEcCtD
Nadolol—Anorexia—Gabapentin—epilepsy syndrome	0.000106	0.000356	CcSEcCtD
Nadolol—Decreased appetite—Pregabalin—epilepsy syndrome	0.000106	0.000354	CcSEcCtD
Nadolol—Fatigue—Pregabalin—epilepsy syndrome	0.000105	0.000351	CcSEcCtD
Nadolol—Hypotension—Gabapentin—epilepsy syndrome	0.000104	0.000349	CcSEcCtD
Nadolol—Nausea—Carbamazepine—epilepsy syndrome	0.000104	0.000348	CcSEcCtD
Nadolol—Constipation—Pregabalin—epilepsy syndrome	0.000104	0.000348	CcSEcCtD
Nadolol—Pain—Pregabalin—epilepsy syndrome	0.000104	0.000348	CcSEcCtD
Nadolol—Syncope—Topiramate—epilepsy syndrome	0.000103	0.000345	CcSEcCtD
Nadolol—Loss of consciousness—Topiramate—epilepsy syndrome	0.000101	0.000338	CcSEcCtD
Nadolol—Insomnia—Gabapentin—epilepsy syndrome	0.000101	0.000338	CcSEcCtD
Nadolol—Nausea—Lamotrigine—epilepsy syndrome	0.000101	0.000337	CcSEcCtD
Nadolol—Cough—Topiramate—epilepsy syndrome	0.0001	0.000336	CcSEcCtD
Nadolol—Paraesthesia—Gabapentin—epilepsy syndrome	0.0001	0.000335	CcSEcCtD
Nadolol—Dyspnoea—Gabapentin—epilepsy syndrome	9.94e-05	0.000333	CcSEcCtD
Nadolol—Hypertension—Topiramate—epilepsy syndrome	9.92e-05	0.000332	CcSEcCtD
Nadolol—Dyspepsia—Gabapentin—epilepsy syndrome	9.82e-05	0.000329	CcSEcCtD
Nadolol—Chest pain—Topiramate—epilepsy syndrome	9.79e-05	0.000328	CcSEcCtD
Nadolol—Carteolol—CYP2D6—epilepsy syndrome	9.74e-05	0.641	CrCbGaD
Nadolol—Decreased appetite—Gabapentin—epilepsy syndrome	9.69e-05	0.000325	CcSEcCtD
Nadolol—Asthenia—Valproic Acid—epilepsy syndrome	9.65e-05	0.000323	CcSEcCtD
Nadolol—Fatigue—Gabapentin—epilepsy syndrome	9.61e-05	0.000322	CcSEcCtD
Nadolol—Body temperature increased—Pregabalin—epilepsy syndrome	9.61e-05	0.000322	CcSEcCtD
Nadolol—Dry mouth—Topiramate—epilepsy syndrome	9.57e-05	0.000321	CcSEcCtD
Nadolol—Pain—Gabapentin—epilepsy syndrome	9.54e-05	0.000319	CcSEcCtD
Nadolol—Constipation—Gabapentin—epilepsy syndrome	9.54e-05	0.000319	CcSEcCtD
Nadolol—Pruritus—Valproic Acid—epilepsy syndrome	9.52e-05	0.000319	CcSEcCtD
Nadolol—Oedema—Topiramate—epilepsy syndrome	9.38e-05	0.000314	CcSEcCtD
Nadolol—Shock—Topiramate—epilepsy syndrome	9.23e-05	0.000309	CcSEcCtD
Nadolol—Diarrhoea—Valproic Acid—epilepsy syndrome	9.2e-05	0.000308	CcSEcCtD
Nadolol—Hyperhidrosis—Topiramate—epilepsy syndrome	9.07e-05	0.000304	CcSEcCtD
Nadolol—Anorexia—Topiramate—epilepsy syndrome	8.94e-05	0.0003	CcSEcCtD
Nadolol—Dizziness—Valproic Acid—epilepsy syndrome	8.89e-05	0.000298	CcSEcCtD
Nadolol—Body temperature increased—Gabapentin—epilepsy syndrome	8.81e-05	0.000295	CcSEcCtD
Nadolol—Hypotension—Topiramate—epilepsy syndrome	8.77e-05	0.000294	CcSEcCtD
Nadolol—Asthenia—Pregabalin—epilepsy syndrome	8.72e-05	0.000292	CcSEcCtD
Nadolol—Pruritus—Pregabalin—epilepsy syndrome	8.6e-05	0.000288	CcSEcCtD
Nadolol—Vomiting—Valproic Acid—epilepsy syndrome	8.55e-05	0.000286	CcSEcCtD
Nadolol—Insomnia—Topiramate—epilepsy syndrome	8.48e-05	0.000284	CcSEcCtD
Nadolol—Rash—Valproic Acid—epilepsy syndrome	8.48e-05	0.000284	CcSEcCtD
Nadolol—Dermatitis—Valproic Acid—epilepsy syndrome	8.47e-05	0.000284	CcSEcCtD
Nadolol—Paraesthesia—Topiramate—epilepsy syndrome	8.42e-05	0.000282	CcSEcCtD
Nadolol—Dyspnoea—Topiramate—epilepsy syndrome	8.36e-05	0.00028	CcSEcCtD
Nadolol—Diarrhoea—Pregabalin—epilepsy syndrome	8.32e-05	0.000279	CcSEcCtD
Nadolol—Dyspepsia—Topiramate—epilepsy syndrome	8.26e-05	0.000277	CcSEcCtD
Nadolol—Decreased appetite—Topiramate—epilepsy syndrome	8.15e-05	0.000273	CcSEcCtD
Nadolol—Fatigue—Topiramate—epilepsy syndrome	8.09e-05	0.000271	CcSEcCtD
Nadolol—Dizziness—Pregabalin—epilepsy syndrome	8.04e-05	0.000269	CcSEcCtD
Nadolol—Constipation—Topiramate—epilepsy syndrome	8.02e-05	0.000269	CcSEcCtD
Nadolol—Pain—Topiramate—epilepsy syndrome	8.02e-05	0.000269	CcSEcCtD
Nadolol—Asthenia—Gabapentin—epilepsy syndrome	8e-05	0.000268	CcSEcCtD
Nadolol—Nausea—Valproic Acid—epilepsy syndrome	7.99e-05	0.000268	CcSEcCtD
Nadolol—Pruritus—Gabapentin—epilepsy syndrome	7.89e-05	0.000264	CcSEcCtD
Nadolol—Vomiting—Pregabalin—epilepsy syndrome	7.73e-05	0.000259	CcSEcCtD
Nadolol—Rash—Pregabalin—epilepsy syndrome	7.67e-05	0.000257	CcSEcCtD
Nadolol—Dermatitis—Pregabalin—epilepsy syndrome	7.66e-05	0.000257	CcSEcCtD
Nadolol—Diarrhoea—Gabapentin—epilepsy syndrome	7.63e-05	0.000256	CcSEcCtD
Nadolol—Body temperature increased—Topiramate—epilepsy syndrome	7.42e-05	0.000248	CcSEcCtD
Nadolol—Dizziness—Gabapentin—epilepsy syndrome	7.37e-05	0.000247	CcSEcCtD
Nadolol—Nausea—Pregabalin—epilepsy syndrome	7.22e-05	0.000242	CcSEcCtD
Nadolol—Vomiting—Gabapentin—epilepsy syndrome	7.09e-05	0.000237	CcSEcCtD
Nadolol—Rash—Gabapentin—epilepsy syndrome	7.03e-05	0.000235	CcSEcCtD
Nadolol—Dermatitis—Gabapentin—epilepsy syndrome	7.02e-05	0.000235	CcSEcCtD
Nadolol—Asthenia—Topiramate—epilepsy syndrome	6.73e-05	0.000225	CcSEcCtD
Nadolol—Pruritus—Topiramate—epilepsy syndrome	6.64e-05	0.000222	CcSEcCtD
Nadolol—Nausea—Gabapentin—epilepsy syndrome	6.62e-05	0.000222	CcSEcCtD
Nadolol—Diarrhoea—Topiramate—epilepsy syndrome	6.42e-05	0.000215	CcSEcCtD
Nadolol—Dizziness—Topiramate—epilepsy syndrome	6.2e-05	0.000208	CcSEcCtD
Nadolol—Vomiting—Topiramate—epilepsy syndrome	5.96e-05	0.0002	CcSEcCtD
Nadolol—Rash—Topiramate—epilepsy syndrome	5.91e-05	0.000198	CcSEcCtD
Nadolol—Dermatitis—Topiramate—epilepsy syndrome	5.91e-05	0.000198	CcSEcCtD
Nadolol—Nausea—Topiramate—epilepsy syndrome	5.57e-05	0.000187	CcSEcCtD
Nadolol—Pindolol—CYP2D6—epilepsy syndrome	5.46e-05	0.359	CrCbGaD
Nadolol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	2.46e-05	0.000203	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT3—epilepsy syndrome	2.46e-05	0.000202	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	2.45e-05	0.000202	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	2.45e-05	0.000202	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	2.45e-05	0.000202	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	2.45e-05	0.000202	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—POMC—epilepsy syndrome	2.44e-05	0.000201	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	2.43e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	2.43e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	2.43e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	2.42e-05	0.000199	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	2.4e-05	0.000198	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	2.4e-05	0.000198	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADAM10—epilepsy syndrome	2.4e-05	0.000198	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	2.4e-05	0.000197	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	2.4e-05	0.000197	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	2.4e-05	0.000197	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL2—epilepsy syndrome	2.39e-05	0.000197	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GBE1—epilepsy syndrome	2.37e-05	0.000195	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	2.37e-05	0.000195	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.35e-05	0.000194	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	2.35e-05	0.000193	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	2.31e-05	0.00019	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.31e-05	0.00019	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.31e-05	0.00019	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	2.3e-05	0.000189	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	2.28e-05	0.000188	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—S100B—epilepsy syndrome	2.27e-05	0.000187	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	2.26e-05	0.000186	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	2.26e-05	0.000186	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	2.26e-05	0.000186	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	2.25e-05	0.000185	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SOCS3—epilepsy syndrome	2.25e-05	0.000185	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	2.24e-05	0.000185	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CDC42—epilepsy syndrome	2.24e-05	0.000185	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ASAH1—epilepsy syndrome	2.22e-05	0.000183	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	2.2e-05	0.000181	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.2e-05	0.000181	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	2.19e-05	0.000181	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	2.18e-05	0.000179	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AVP—epilepsy syndrome	2.17e-05	0.000179	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—STXBP1—epilepsy syndrome	2.16e-05	0.000178	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	2.15e-05	0.000177	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	2.13e-05	0.000176	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.12e-05	0.000174	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	2.12e-05	0.000174	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NT5E—epilepsy syndrome	2.11e-05	0.000174	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALAD—epilepsy syndrome	2.11e-05	0.000174	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	2.1e-05	0.000173	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.1e-05	0.000173	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	2.07e-05	0.00017	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.06e-05	0.000169	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HES1—epilepsy syndrome	2.05e-05	0.000169	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.04e-05	0.000168	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	2.01e-05	0.000166	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	2.01e-05	0.000166	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	2e-05	0.000165	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2e-05	0.000164	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	2e-05	0.000164	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FYN—epilepsy syndrome	2e-05	0.000164	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—H2AFX—epilepsy syndrome	1.99e-05	0.000164	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MEF2C—epilepsy syndrome	1.99e-05	0.000163	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.97e-05	0.000162	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.96e-05	0.000161	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.95e-05	0.000161	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.95e-05	0.00016	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.95e-05	0.00016	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.93e-05	0.000159	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.92e-05	0.000158	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.91e-05	0.000157	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.91e-05	0.000157	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NGF—epilepsy syndrome	1.9e-05	0.000156	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.9e-05	0.000156	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.89e-05	0.000156	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.88e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.88e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.88e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.88e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.88e-05	0.000155	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.86e-05	0.000153	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.85e-05	0.000153	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.85e-05	0.000153	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.85e-05	0.000152	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR5—epilepsy syndrome	1.85e-05	0.000152	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.84e-05	0.000151	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.84e-05	0.000151	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.84e-05	0.000151	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.84e-05	0.000151	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.84e-05	0.000151	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.81e-05	0.000149	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.81e-05	0.000149	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—epilepsy syndrome	1.81e-05	0.000149	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.8e-05	0.000148	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.78e-05	0.000146	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.75e-05	0.000144	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.75e-05	0.000144	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.75e-05	0.000144	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.74e-05	0.000143	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.73e-05	0.000142	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.72e-05	0.000142	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TSC2—epilepsy syndrome	1.72e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.71e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AGT—epilepsy syndrome	1.71e-05	0.000141	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.71e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.71e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.71e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.7e-05	0.00014	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.7e-05	0.00014	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.7e-05	0.00014	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.69e-05	0.000139	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.69e-05	0.000139	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.68e-05	0.000139	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOE—epilepsy syndrome	1.68e-05	0.000138	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.66e-05	0.000137	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.66e-05	0.000137	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.66e-05	0.000137	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.66e-05	0.000137	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.66e-05	0.000136	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.65e-05	0.000136	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	1.65e-05	0.000135	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.63e-05	0.000134	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.62e-05	0.000133	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.6e-05	0.000132	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.6e-05	0.000132	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.6e-05	0.000131	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.59e-05	0.000131	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.58e-05	0.00013	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	1.58e-05	0.00013	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	1.58e-05	0.00013	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.57e-05	0.000129	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.57e-05	0.000129	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.56e-05	0.000129	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.56e-05	0.000129	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.56e-05	0.000129	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.56e-05	0.000128	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.56e-05	0.000128	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.55e-05	0.000128	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.54e-05	0.000127	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.53e-05	0.000126	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.53e-05	0.000126	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.53e-05	0.000126	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.53e-05	0.000126	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.52e-05	0.000125	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.52e-05	0.000125	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.5e-05	0.000123	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.49e-05	0.000122	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.46e-05	0.00012	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.45e-05	0.00012	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.45e-05	0.000119	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	1.44e-05	0.000119	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.43e-05	0.000117	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.42e-05	0.000117	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.42e-05	0.000117	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.42e-05	0.000117	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	1.41e-05	0.000116	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.39e-05	0.000115	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.39e-05	0.000114	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.35e-05	0.000111	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.33e-05	0.00011	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.33e-05	0.00011	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	1.32e-05	0.000108	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1.3e-05	0.000107	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1.3e-05	0.000107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.29e-05	0.000106	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	1.28e-05	0.000105	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	1.26e-05	0.000104	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.24e-05	0.000102	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.22e-05	0.0001	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.21e-05	9.97e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.2e-05	9.91e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	1.19e-05	9.81e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	1.18e-05	9.75e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	1.18e-05	9.75e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.18e-05	9.72e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.18e-05	9.7e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	1.16e-05	9.56e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	1.16e-05	9.54e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	1.15e-05	9.5e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	1.15e-05	9.49e-05	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.15e-05	9.44e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.14e-05	9.37e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.13e-05	9.27e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.11e-05	9.17e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.1e-05	9.07e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.1e-05	9.02e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.09e-05	8.94e-05	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.08e-05	8.87e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.07e-05	8.82e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.07e-05	8.82e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	1.07e-05	8.79e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.05e-05	8.63e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.04e-05	8.53e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.03e-05	8.51e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	1.02e-05	8.38e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	1.02e-05	8.37e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	1.01e-05	8.31e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	9.97e-06	8.2e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	9.96e-06	8.2e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	9.95e-06	8.19e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	9.83e-06	8.09e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	9.79e-06	8.06e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	9.76e-06	8.04e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	9.75e-06	8.02e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLCB1—epilepsy syndrome	9.72e-06	8e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TH—epilepsy syndrome	9.68e-06	7.97e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	9.55e-06	7.86e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	9.4e-06	7.74e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	9.36e-06	7.7e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	9.31e-06	7.66e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	9.19e-06	7.57e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	9.16e-06	7.54e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	9.06e-06	7.46e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	8.56e-06	7.05e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	8.38e-06	6.89e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	8.38e-06	6.89e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	8.19e-06	6.74e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	8.08e-06	6.65e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAT—epilepsy syndrome	7.97e-06	6.56e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	7.57e-06	6.23e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	7.41e-06	6.1e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GPX1—epilepsy syndrome	7.21e-06	5.94e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	7.03e-06	5.78e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	6.89e-06	5.67e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	6.88e-06	5.66e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	6.74e-06	5.55e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.4e-06	5.27e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	6.34e-06	5.22e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AGT—epilepsy syndrome	6.32e-06	5.2e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.26e-06	5.15e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	6.2e-06	5.1e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—epilepsy syndrome	6.2e-06	5.1e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	6.16e-06	5.07e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	6.02e-06	4.96e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.99e-06	4.93e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	5.86e-06	4.82e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	5.81e-06	4.78e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	5.78e-06	4.76e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	5.68e-06	4.68e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	5.52e-06	4.55e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	5.4e-06	4.45e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	5.38e-06	4.43e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—POMC—epilepsy syndrome	5.32e-06	4.38e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	5.26e-06	4.33e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—epilepsy syndrome	4.85e-06	3.99e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.25e-06	3.49e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3.43e-06	2.82e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	3.36e-06	2.76e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.13e-06	1.76e-05	CbGpPWpGaD
